Verity & Verity Has Upped Metlife (MET) Stake; Acm Research – Class A (ACMR) Shorts Decreased By 8.11%

MetLife, Inc. (NYSE:MET) Logo

Acm Research Inc – Class A (NASDAQ:ACMR) had a decrease of 8.11% in short interest. ACMR’s SI was 411,500 shares in February as released by FINRA. Its down 8.11% from 447,800 shares previously. With 34,100 avg volume, 12 days are for Acm Research Inc – Class A (NASDAQ:ACMR)’s short sellers to cover ACMR’s short positions. The SI to Acm Research Inc – Class A’s float is 4.64%. The stock decreased 1.48% or $0.14 during the last trading session, reaching $9.34. About 40,161 shares traded or 91.26% up from the average. ACM Research, Inc. (NASDAQ:ACMR) has risen 75.93% since February 14, 2018 and is uptrending. It has outperformed by 75.93% the S&P500. Some Historical ACMR News: 08/05/2018 – ACM RESEARCH INC QTRLY SHR LOSS $0.18; 08/05/2018 – ACM Research Backs 2018 Rev $65M; 21/04/2018 DJ ACM Research Inc Class A, Inst Holders, 1Q 2018 (ACMR); 08/05/2018 – ACM RESEARCH INC ACMR.O SEES FY 2018 REVENUE $65 MLN; 24/05/2018 – ACM Research Non-Deal Roadshow Set By Benchmark for May. 31; 08/05/2018 – ACM Research 1Q Loss/Shr 18c; 29/05/2018 – ACM Research to Participate in Upcoming Investor Conferences; 08/05/2018 – ACM RESEARCH INC QTRLY ADJ SHR LOSS $0.04

Verity & Verity Llc increased Metlife Inc (MET) stake by 20.21% reported in 2018Q3 SEC filing. Verity & Verity Llc acquired 11,219 shares as Metlife Inc (MET)’s stock declined 13.12%. The Verity & Verity Llc holds 66,744 shares with $3.12 million value, up from 55,525 last quarter. Metlife Inc now has $42.39 billion valuation. The stock decreased 0.20% or $0.09 during the last trading session, reaching $44.22. About 5.68M shares traded. MetLife, Inc. (NYSE:MET) has declined 26.13% since February 14, 2018 and is downtrending. It has underperformed by 26.13% the S&P500. Some Historical MET News: 02/05/2018 – MetLife 1Q Operating Revenue $15.15B; 30/03/2018 – MetLife Partners With China Net Giant Tencent’s WeSure — MarketWatch; 07/03/2018 – METLIFE SAYS CFO MARLENE DEBEL TO LEAD METLIFE RETIREMENT; 07/03/2018 – MARLENE DEBEL TO LEAD METLIFE RETIREMENT; 16/05/2018 – MetLife Launches PlanSmart® Financial Wellness; 03/05/2018 – Christine Angino, Formerly of MetLife, Joins ALTO Real Estate Funds as Vice President of Acquisitions; 29/03/2018 – April 6th Deadline Alert: The Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against MetLife, Inc. (MET); 08/03/2018 – The Klein Law Firm Reminds Investors of a Class Action Filed on Behalf of MetLife, Inc. Shareholders and a Lead Plaintiff Deadl; 05/04/2018 – METLIFE 24 HOUR DEADLINE ALERT: Approximately 24 Hours Remain; ClaimsFiler Reminds Investors of Deadline in Class Action Lawsuit against MetLife, Inc. – MET; 22/05/2018 – METLIFE INC – ON TRACK TO RETURN APPROXIMATELY $5 BLN OF CAPITAL TO CO’S SHAREHOLDERS IN 2018

Among 5 analysts covering MetLife (NYSE:MET), 3 have Buy rating, 0 Sell and 2 Hold. Therefore 60% are positive. MetLife had 5 analyst reports since August 17, 2018 according to SRatingsIntel. RBC Capital Markets maintained MetLife, Inc. (NYSE:MET) on Monday, December 17 with “Outperform” rating. Credit Suisse maintained it with “Outperform” rating and $63 target in Friday, August 17 report. As per Monday, October 8, the company rating was maintained by UBS. Bank of America upgraded the shares of MET in report on Wednesday, January 16 to “Buy” rating. The company was maintained on Tuesday, November 13 by Morgan Stanley.

Investors sentiment decreased to 0.86 in Q3 2018. Its down 0.03, from 0.89 in 2018Q2. It worsened, as 47 investors sold MET shares while 324 reduced holdings. 81 funds opened positions while 237 raised stakes. 739.18 million shares or 1.70% less from 751.98 million shares in 2018Q2 were reported. Verity & Verity Ltd Limited Liability Company invested in 0.75% or 66,744 shares. Cambridge Inv Rech Advisors Inc invested in 0.03% or 64,816 shares. Adirondack Rech Mngmt Inc holds 9,303 shares or 0.16% of its portfolio. Nbt National Bank & Trust N A invested 0.08% of its portfolio in MetLife, Inc. (NYSE:MET). Fairfield Bush And accumulated 0.08% or 6,043 shares. 1832 Asset LP holds 1,040 shares. Cullen Capital Ltd invested in 1.08M shares or 1.85% of the stock. Century owns 1.46 million shares or 0.07% of their US portfolio. Calamos Wealth Mngmt Lc holds 85,909 shares or 0.5% of its portfolio. Amalgamated Bancorporation holds 108,984 shares or 0.13% of its portfolio. Diamond Hill Mngmt Inc, a Ohio-based fund reported 10.89M shares. The Connecticut-based Arga Inv Mgmt LP has invested 0.2% in MetLife, Inc. (NYSE:MET). Strs Ohio accumulated 869,559 shares or 0.18% of the stock. North Star Invest Mgmt Corp invested in 9,720 shares or 0.05% of the stock. Confluence Wealth Mngmt Ltd Liability Company has invested 0.19% in MetLife, Inc. (NYSE:MET).

Verity & Verity Llc decreased Hasbro Inc (NASDAQ:HAS) stake by 3,879 shares to 11,179 valued at $1.18M in 2018Q3. It also reduced Raytheon Co (NYSE:RTN) stake by 2,014 shares and now owns 29,108 shares. Eversource Energy was reduced too.

More notable recent MetLife, Inc. (NYSE:MET) news were published by: Seekingalpha.com which released: “MetLife -1.9% as Q4 revenue disappoints – Seeking Alpha” on February 06, 2019, also Bizjournals.com with their article: “Fortune 100 company buys heart of Bellevue mall overhaul – Nashville Business Journal” published on January 25, 2019, Seekingalpha.com published: “MetLife to pay $19.7M penalty over New York insurance law violations – Seeking Alpha” on January 28, 2019. More interesting news about MetLife, Inc. (NYSE:MET) were released by: Businesswire.com and their article: “MetLife Chairman, President & CEO to Speak at Bank of America Merrill Lynch 2019 Insurance Conference – Business Wire” published on February 07, 2019 as well as Globenewswire.com‘s news article titled: “Research Report Identifies MetLife, Gentherm, Robert Half International, Regis, Gevo, and Digital Turbine with Renewed Outlook — Fundamental Analysis, Calculating Forward Movement – GlobeNewswire” with publication date: January 24, 2019.

MetLife, Inc. (NYSE:MET) Institutional Positions Chart